Ovarian cancer
Conditions
Interventions
None listed
Sponsors
Yokohama City University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patinets whose pre-treatment serum samples are obetained. 2.Patients who submitted the documment for written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients who are judged as being inappropriate for this study 2. Patients during pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in serum concentrations of target protein and CA125 before and after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Complementaly effects of the target protein and CA125 | — |
Countries
Japan
Contacts
Public ContactRuiz Yokota Naho
Yokohama City University Department of Obstetrics and Gynecology
Outcome results
None listed